蓝丰生化(002513) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥378,109,304.42, a decrease of 0.94% compared to ¥381,711,743.06 in the same period last year[5] - The net loss attributable to shareholders was ¥30,509,968.18, representing a 107.17% increase in losses from ¥14,727,136.62 in the previous year[5] - Total operating revenue for Q1 2024 was CNY 378.11 million, a decrease of 0.42% compared to CNY 381.71 million in the same period last year[16] - Net loss for Q1 2024 was CNY 42.48 million, compared to a net loss of CNY 14.81 million in Q1 2023, representing a significant increase in losses[17] - The basic and diluted earnings per share for Q1 2024 were both negative CNY 0.0825, compared to negative CNY 0.0433 in Q1 2023[18] Cash Flow - The net cash flow from operating activities was -¥98,675,401.02, a decline of 194.98% compared to -¥33,451,158.01 in the same period last year[5] - Cash flow from operating activities showed a net outflow of CNY 98.68 million, worsening from a net outflow of CNY 33.45 million in the same quarter last year[19] - The net cash flow from investment activities was -15,039,484.92 CNY, compared to -818,889.30 CNY in the previous year[20] - Cash inflow from financing activities totaled 205,136,621.05 CNY, up from 105,030,100.00 CNY year-over-year[20] - The net cash flow from financing activities was 131,847,903.81 CNY, significantly higher than 34,357,842.57 CNY in the same period last year[20] - The cash and cash equivalents at the end of the period increased to 35,217,795.77 CNY from 8,906,465.49 CNY year-over-year[20] Assets and Liabilities - The company's total assets decreased by 3.41% to ¥3,283,814,284.87 from ¥3,399,589,930.03 at the end of the previous year[5] - Total current assets decreased from CNY 1,575,672,725.35 to CNY 1,462,962,235.41, a decline of approximately 7.14%[12] - Total non-current assets slightly decreased from CNY 1,823,917,204.68 to CNY 1,820,852,049.46, a marginal decline of about 0.17%[13] - The company reported a total liability of CNY 3.07 billion, a decrease from CNY 3.15 billion in the previous quarter[17] - Total current liabilities decreased from CNY 2,517,475,798.31 to CNY 2,410,380,085.10, a reduction of about 4.24%[13] Shareholder Information - Total number of common shareholders at the end of the reporting period is 15,336[10] - The largest shareholder, Zheng Xu, holds 18.04% of shares, totaling 67,457,432 shares, with 33,500,000 shares pledged[10] Inventory and Receivables - Accounts receivable decreased by 28.12% to ¥261,193,454.89, primarily due to an increase in cash collections[8] - Inventory increased by 68.40% to ¥282,520,812.57, mainly due to an increase in raw material stockpiling[8] - Accounts receivable decreased from CNY 363,357,301.83 to CNY 261,193,454.89, a reduction of about 28.14%[12] - Inventory increased significantly from CNY 167,768,426.09 to CNY 282,520,812.57, an increase of approximately 68.25%[12] Research and Development - Research and development expenses surged by 923.42% to ¥27,074,326.90, reflecting increased investment in R&D activities[8] - Research and development expenses surged to CNY 27.07 million, a substantial increase from CNY 2.65 million in the previous year, indicating a focus on innovation[16] Other Income and Subsidies - The company received government subsidies amounting to ¥7,108,985.58, a 236.77% increase compared to ¥2,110,950.00 in the previous year[8] - The company recorded other income of CNY 7.11 million, an increase from CNY 2.11 million in the same period last year[17] Borrowings - Short-term borrowings increased from CNY 202,639,026.75 to CNY 216,187,674.25, an increase of approximately 6.77%[13] - Long-term borrowings increased from CNY 408,459,555.56 to CNY 436,459,555.56, an increase of about 6.85%[13] - The company received 98,000,000.00 CNY in borrowings during the quarter, compared to 55,530,100.00 CNY in the previous year[20] Audit Status - The first quarter report was not audited[21]